-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Duration of Therapy for Provoked and Unprovoked VTE in Pediatric Patients

Program: Special-Interest Sessions
Session: ASH Clinical Practice Guidelines on Pediatric Venous Thromboembolism (VTE)
Hematology Disease Topics & Pathways:
Bleeding and Clotting, Clinical Practice (Health Services and Quality), Thromboembolism, Diseases
Saturday, December 7, 2024, 9:30 AM-11:00 AM

Marisol Betensky, MD, MPH

Johns Hopkins All Children's Hospital, Saint Petersburg, FL

Disclosures: Betensky: Boston Scientific: Honoraria; Aziyo: Honoraria; Abbot: Honoraria; Zoll: Honoraria; NHLBI K23: Research Funding.

See more of: ASH Clinical Practice Guidelines on Pediatric Venous Thromboembolism (VTE)
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>